Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana

NCT05986084 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Pre-Exposure Prophylaxis (PrEP)
Breast Feeding

Interventions

DRUG: Cabotegravir Injection [Apretude]

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]
[object Object]